Source: International Journal of Nanomedicine. Unidades: IF, FCF
Assunto: ENTEROPATIAS INFLAMATÓRIAS
ABNT
BROERING, Milena Fronza et al. Development of Ac2-26 mesoporous microparticle system as a potential therapeutic agent for inflammatory bowel diseases. International Journal of Nanomedicine, v. 19, p. 3537–3554, 2024Tradução . . Disponível em: https://dx.doi.org/10.2147/IJN.S451589. Acesso em: 31 out. 2024.APA
Broering, M. F., Oseliero Filho, P. L., Borges, P. P., Silva, L. C. C. da, Knirsch, M. C., Xavier, L. F., et al. (2024). Development of Ac2-26 mesoporous microparticle system as a potential therapeutic agent for inflammatory bowel diseases. International Journal of Nanomedicine, 19, 3537–3554. doi:10.2147/IJN.S451589NLM
Broering MF, Oseliero Filho PL, Borges PP, Silva LCC da, Knirsch MC, Xavier LF, Scharf PR dos S, Sandri S, Stephano MA, Oliveira FA de, Sayed IM, Gamarra LF, Das S, Fantini MC de A, Farsky SHP. Development of Ac2-26 mesoporous microparticle system as a potential therapeutic agent for inflammatory bowel diseases [Internet]. International Journal of Nanomedicine. 2024 ; 19 3537–3554.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.2147/IJN.S451589Vancouver
Broering MF, Oseliero Filho PL, Borges PP, Silva LCC da, Knirsch MC, Xavier LF, Scharf PR dos S, Sandri S, Stephano MA, Oliveira FA de, Sayed IM, Gamarra LF, Das S, Fantini MC de A, Farsky SHP. Development of Ac2-26 mesoporous microparticle system as a potential therapeutic agent for inflammatory bowel diseases [Internet]. International Journal of Nanomedicine. 2024 ; 19 3537–3554.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.2147/IJN.S451589